Paul Newhouse Archive — Page 1 of 2
-
February 12, 2020
Study seeks link between menopause, Alzheimer’s
Beginning this month, researchers from VUMC and the University of Vermont are launching a study to examine whether cognitive changes that occur at menopause for some women are related to an increased risk for Alzheimer's disease. -
November 2, 2017
Study explores nicotine patch to treat mild cognitive impairment
Three years ago Reece Dean, of Nashville’s Bellevue community, retired at age 69 from a career as a busy truck driver. Mary Ann, his wife, began to notice some changes in his memory and behavior since he was home more consistently. -
August 7, 2017
Vanderbilt begins Phase 1 trials of new Alzheimer’s drug
Developed at Vanderbilt, VU319 is designed to precisely target a specific neuron receptor associated with cognitive function while avoiding potentially dangerous side effects. -
March 2, 2017
Clues found to recurrent depression
Women who have had repeated depressive episodes tend to pay more attention to negative emotional information, suggesting that they may benefit from cognitive therapy to build new, more positive pathways in their brains. -
December 27, 2016
Investigational new drug for Alzheimer’s scheduled for first study in humans
Vanderbilt University scientists have received notification from the U.S. Food and Drug Administration that testing in humans may proceed for an investigational new drug for Alzheimer's disease after more than 10 years of research by scientists at Vanderbilt University and Vanderbilt University Medical Center. -
October 29, 2015
Study explores nicotine patch to treat memory loss
Vanderbilt University Medical Center has received a $9.4 million grant from the National Institute on Aging (NIA) to test the effectiveness of a transdermal nicotine patch in improving memory loss in older adults with mild cognitive impairment (MCI), a precursor to Alzheimer’s disease. -
December 16, 2013
Cancer drug enhances cognition
The breast cancer drug tamoxifen improves cognitive performance in post-menopausal women.